NYSE:ADCT | Free Cash Flow | ADC Therapeutics SA

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$29.71M$32,000.00-$29.74M
2025-12-31-$31.12M$0.00-$31.12M
2025-03-31-$56.33M$264,000.00-$56.6M
2024-12-31-$21.85M$90,000.00-$21.94M
2024-03-31-$44.1M$531,000.00-$44.63M
2023-12-31-$31.63M$327,000.00-$31.96M
2023-03-31-$15.39M$1.02M-$16.41M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$141.17M$264,000.00-$141.44M
2024-12-31-$123.84M$867,000.00-$124.7M
2023-12-31-$118.69M$3.22M-$121.9M
2022-12-31-$138.31M$687,000.00-$139M